TG Therapeutics (TGTX) Earnings Date, Estimates & Call Transcripts $35.61 -0.37 (-1.03%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$35.72 +0.12 (+0.32%) As of 07:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TG Therapeutics Earnings Summary TG Therapeutics posted Q1 2025 earnings on May 7, 2025, reporting an EPS of $0.03, which missed the consensus estimate of $0.19 by $0.16. Quarterly revenue rose 90.4% year-over-year to $120.86 million, above the consensus estimate of $117.07 million. With a trailing EPS of $0.24 and a P/E Ratio of 148.38, TG Therapeutics' earnings are expected to grow 1,150.00% next year, from $0.08 to $1.00 per share. Upcoming Q2 Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (May. 7) $0.19 Actual EPS (May. 7) $0.03 Missed By -$0.16 Actual Revenue (May. 7) $120.86MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)TGTX Upcoming EarningsTG Therapeutics' Q2 2025 earnings is scheduled for Tuesday, August 5, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get TG Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TG Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTGTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TGTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. TG Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20252$0.21$0.28$0.25Q2 20252$0.30$0.32$0.31Q3 20252$0.37$0.40$0.39Q4 20252$0.34$0.42$0.38 TG Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)-------5/7/2025Q1 2025$0.19$0.03 -$0.16$0.03$117.07M$120.86M3/3/2025Q4 2024$0.08$0.15+$0.07$0.15$100.67M$108.19M11/4/2024Q3 2024$0.03$0.02 -$0.01$0.02$81.68M$83.90M8/6/2024Q2 2024-$0.04$0.04+$0.08$0.04$65.92M$73.47M5/1/2024Q1 2024-$0.05-$0.07 -$0.02-$0.07$54.60M$63.47M2/28/2024Q4 2023-$0.12-$0.09+$0.03-$0.09$40.06M$43.97M11/1/2023Q3 2023$0.29$0.73+$0.44$0.73$23.91M$165.80M8/1/2023Q2 2023-$0.26-$0.34 -$0.08-$0.34$17.39M$16.07M TG Therapeutics Earnings - Frequently Asked Questions When is TG Therapeutics' earnings date? TG Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on TGTX's earnings history. What guidance has TG Therapeutics issued on next quarter's earnings? TG Therapeutics issued an update on its FY 2025 earnings guidance on Monday, May, 5th. The company issued revenue guidance of $575.0 million-$575.0 million, compared to the consensus revenue estimate of $553.0 million. Did TG Therapeutics beat their earnings estimates last quarter? In the previous quarter, TG Therapeutics (NASDAQ:TGTX) missed the analysts' consensus estimate of $0.19 by $0.16 with a reported earnings per share (EPS) of $0.03. Learn more on analysts' earnings estimate vs. TGTX's actual earnings. How can I listen to TG Therapeutics' earnings conference call? The conference call for TG Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read TG Therapeutics' conference call transcript? The conference call transcript for TG Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does TG Therapeutics generate each year? TG Therapeutics (NASDAQ:TGTX) has a recorded annual revenue of $329 million. How much profit does TG Therapeutics generate each year? TG Therapeutics (NASDAQ:TGTX) has a recorded net income of $23.38 million. TGTX has generated $0.24 earnings per share over the last four quarters. What is TG Therapeutics' price-to-earnings ratio? TG Therapeutics (NASDAQ:TGTX) has a trailing price-to-earnings ratio of 148.38 and a forward price-to-earnings ratio of 445.13. What is TG Therapeutics' EPS forecast for next year? TG Therapeutics' earnings are expected to grow from $0.08 per share to $1.00 per share in the next year, which is a 1,150.00% increase. More Earnings Resources from MarketBeat Related Companies Teva Pharmaceutical Industries Earnings Date Insmed Earnings Date Summit Therapeutics Earnings Date Intra-Cellular Therapies Earnings Date Genmab A/S Earnings Date Dr. Reddy's Laboratories Earnings Date Qiagen Earnings Date Moderna Earnings Date Ascendis Pharma A/S Earnings Date Viatris Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NASDAQ:TGTX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
